Related Experiment Video
Updated: Jun 17, 2025

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
Impact of Allergic Rhinitis Control on Work Productivity and Costs: A Real-World Data MASK-air Study.
Rafael José Vieira1, Luís Filipe Azevedo1, Ana Margarida Pereira2
1MEDicina da Comunidade, Informação e Decisão em Saúde (MEDCIDS)-Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal; CINTESIS@RISE-Centre for Health Technology and Services Research, Health Research Network, Faculty of Medicine, University of Porto, Porto, Portugal.
Allergic rhinitis (AR) significantly reduces work productivity, especially when poorly controlled. This impacts individuals with AR and asthma the most, highlighting the economic burden of the condition.
Area of Science:
- Allergy and Immunology
- Occupational Health
- Health Economics
Background:
- Allergic rhinitis (AR) imposes a considerable socioeconomic burden due to diminished work productivity.
- Understanding the impact of AR on the workforce is crucial for economic assessment.
Purpose of the Study:
- To investigate the effect of allergic rhinitis on work productivity.
- To quantify the indirect economic costs associated with AR across 40 countries.
Main Methods:
- A cross-sectional study utilized patient data from the MASK-air app.
- The Work Productivity and Activity Impairment Questionnaire: Allergy Specific assessed work impairment (presenteeism and absenteeism).
- Indirect costs were estimated weekly per country, considering different rhinitis control levels and the presence of asthma.
Main Results:
- Poor AR control led to a median presenteeism impact of 60.7%, significantly higher than partial (25.0%) or good (4.4%) control.
- Indirect costs due to presenteeism in poorly controlled weeks varied widely, from $65.7 PPP in Brazil to $693.6 PPP in Iceland.
- Patients with AR and asthma experienced greater work impairment (68.4%) compared to those with AR alone (39.1%), particularly during poorly controlled periods.
Conclusions:
- Inadequate control of allergic rhinitis is linked to reduced work productivity and increased indirect economic costs.
- The economic burden of AR is substantial, with a pronounced impact on individuals who also have asthma.
- These findings underscore the need for effective AR management to mitigate socioeconomic consequences.
Related Concept Videos
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-I: Introduction
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Allergic Reactions

